Alkyl Amines Chemicals
- P/E
- 36.10
Key Fundamentals
MicrocapChemicals & PetrochemicalsChemicalsPrice-based figures as of · EPS basis: Standalone · TTM
- ROCE
- 16.60%
- Debt to Equity
- 0.00
- EPS (TTM)
- ₹44.03
- Book Value
- ₹299.79
- Market Cap
- —
- P/E (TTM)
- 36.10
- P/B
- 5.30
- ROE
- 12.30%
- Dividend Yield
- 0.60%
- EBITDA
- ₹264 Cr
- 52W High
- ₹2,115.00
- 52W Low
- ₹1,212.00
- Day Range
- ₹1,581.00 – ₹1,656.90
- Volume
- 1,34,314
Peer Comparison
Commodities › Chemicals › Specialty Chemicals
| ₹1,510.20 | 58.04 | ₹1,54,107 Cr | 13.72 | 1.42% | 23.90% | 31.00% | ₹15,399 Cr | ₹2,677 Cr | |
| ₹4,613.30 | 83.76 | ₹49,073 Cr | 6.04 | 0.07% | 7.82% | 9.64% | ₹5,303 Cr | ₹600 Cr | |
| ₹8,785.00 | 57.03 | ₹44,060 Cr | 10.10 | 0.09% | 19.60% | 21.00% | ₹3,634 Cr | ₹789 Cr | |
| ₹1,578.40 | 27.48 | ₹20,919 Cr | 3.32 | 0.49% | 9.82% | 11.40% | ₹8,575 Cr | ₹784 Cr | |
| ₹1,540.70 | 86.90 | ₹20,030 Cr | 7.88 | 0.00% | 9.66% | 11.90% | ₹1,231 Cr | ₹235 Cr | |
| ₹447.55 | 30.57 | ₹15,838 Cr | 2.59 | 0.23% | 7.13% | 6.86% | ₹9,010 Cr | ₹531 Cr | |
| ₹5,156.50 | 19.67 | ₹14,827 Cr | 2.31 | 0.59% | 11.50% | 14.90% | ₹6,969 Cr | ₹788 Cr | |
| ₹1,589.50 | 36.10 | ₹8,221 Cr | 5.30 | 0.60% | 12.30% | 16.60% | ₹1,658 Cr | ₹225 Cr | |
| Median 8 companies | ₹1,583.95 | 46.57 | ₹20,474 Cr | 5.67 | 0.36% | 10.66% | 13.40% | ₹6,136 Cr | ₹692 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 78
- Strong
- Returns, margins, earnings quality 22% weight
- Valuation
- 34
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 27
- Poor
- Sales & profit trajectory 9% weight
- Financial Health
- 90
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 35
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 57
- Good
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
3- Company has reduced debt.
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 30.1%
Weaknesses
2- The company has delivered a poor sales growth of 4.33% over past five years.
- Company has a low return on equity of 12.8% over last 3 years.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 12 | 6 | 1 |
| Oscillators | Bearish | 2 | 6 | 1 |
| Moving Averages | Strong Bearish | 10 | 0 | 0 |
Oscillators
Bearish
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 34.60
- Neutral
- MACD (12,26,9)
- −64.05
- Bearish
- SMA (50)
- 1,842.95
- Bearish
- SMA (200)
- 1,690.46
- Bearish
As of
Analyst Rating
2 of 3 analysts rate Buy, 1 Hold, 0 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | +12.24% |
|---|---|
| 5Y | +4.34% |
| 3Y | −3.00% |
| 1Y | −2.29% |
| TTM | +5.07% |
Net profit
| 10Y | +13.67% |
|---|---|
| 5Y | −9.41% |
| 3Y | −7.71% |
| 1Y | −3.23% |
| TTM | +20.97% |
Operating cash flow
| 10Y | +9.00% |
|---|---|
| 5Y | −8.07% |
| 3Y | −1.22% |
| 1Y | −9.13% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | −0.25 pp |
|---|---|
| 5Y | −16.07 pp |
| 3Y | −2.13 pp |
| 1Y | +0.04 pp |
| TTM | +2.25 pp |
Revenue by year
| Mar 2017 | ₹501 Cr |
|---|---|
| Mar 2018 | ₹616 Cr |
| Mar 2019 | ₹846 Cr |
| Mar 2020 | ₹993 Cr |
| Mar 2021 | ₹1,242 Cr |
| Mar 2022 | ₹1,542 Cr |
| Mar 2023 | ₹1,683 Cr |
| Mar 2024 | ₹1,441 Cr |
| Mar 2025 | ₹1,572 Cr |
| Mar 2026 | ₹1,536 Cr |
Net profit by year
| Mar 2017 | ₹50.00 Cr |
|---|---|
| Mar 2018 | ₹64.00 Cr |
| Mar 2019 | ₹84.00 Cr |
| Mar 2020 | ₹215 Cr |
| Mar 2021 | ₹295 Cr |
| Mar 2022 | ₹225 Cr |
| Mar 2023 | ₹229 Cr |
| Mar 2024 | ₹149 Cr |
| Mar 2025 | ₹186 Cr |
| Mar 2026 | ₹180 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Alkyl Amines Chemicals Ltd is a nearly debt-free specialty chemicals company with a market cap of ₹9,144 Cr trading at a PE of 50.8x. The company faces a period of declining sales and profit growth with TTM revenue contracting 2% and profits down 3%, while its 10-year track record shows compounded sales growth of 12% and profit growth of 14%.
- Company is almost debt-free, having actively reduced debt, which provides financial flexibility and lower interest burden
- Strong 10-year compounded sales CAGR of 12% demonstrates long-term revenue scaling ability in specialty chemicals
- 10-year compounded profit growth of 14% indicates historically robust earnings power over a full business cycle
- 10-year average ROE of 21% reflects a historically high-quality capital allocation track record
- Healthy dividend payout ratio of 30.1% signals management commitment to returning capital to shareholders
- 10-year stock CAGR of 30% shows significant long-term value creation for shareholders despite recent correction
- Price-to-book of 5.96x combined with near-zero debt suggests the premium is backed by asset quality rather than leverage
- Current dividend yield of 0.56% provides some income cushion during the ongoing growth slowdown phase
- PE ratio of 50.8x is elevated, especially given TTM sales decline of 2% and profit decline of 3%, suggesting the stock prices in growth that is not materializing
- 5-year compounded sales growth of only 4% signals a structural slowdown from the 12% 10-year CAGR
- 5-year compounded profit CAGR is negative at -9%, indicating sustained earnings deterioration over a meaningful period
- ROE has declined from a 10-year average of 21% to just 12% last year, reflecting diminishing returns on equity capital
- 3-year ROE of 13% versus 5-year ROE of 16% shows a continuing downward trajectory in profitability
- Stock has declined 24% over the past 1 year and shows a 3-year CAGR of -10%, indicating sustained de-rating by the market
- 3-year compounded sales growth of -3% suggests the revenue contraction is not a one-off but a multi-year trend
- 5-year stock CAGR of -16% indicates prolonged destruction of shareholder value from peak levels
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Alkyl Amines is rewarding shareholders with a ₹10/share dividend while investing in capacity expansion. The anti-dumping duty approval provides a protective tailwind against cheap imports. No visible headwinds from recent news, though limited data makes it difficult to assess broader trend direction. The combination of growth capex and trade protection suggests management confidence in near-term demand.
- ₹10 dividend declared at AGM Jul 3
Alkyl Amines declared a dividend of ₹10 per share at its 46th AGM on July 3, 2026. The company also highlighted capacity expansion plans and received anti-dumping duty approval, supporting margin protection.
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 410 | 352 | 322 | 357 | 400 | 415 | 371 | 386 | 406 | 389 | 354 | 387 | 528 | 491 |
| Expenses | 336 | 304 | 262 | 288 | 321 | 341 | 301 | 318 | 329 | 319 | 287 | 316 | 394 | 393 |
| Operating Profit | 74 | 48 | 60 | 69 | 79 | 74 | 71 | 68 | 77 | 70 | 67 | 71 | 134 | 98 |
| OPM % | 18% | 14% | 19% | 19% | 20% | 18% | 19% | 18% | 19% | 18% | 19% | 18% | 25% | 20% |
| Other Income | 5 | 2 | 5 | 3 | 5 | 9 | 7 | 9 | 8 | 7 | 8 | 8 | 9 | 11 |
| Interest | 1 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 12 | 13 | 17 | 17 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 |
| PBT | 66 | 36 | 46 | 53 | 66 | 64 | 59 | 59 | 66 | 59 | 57 | 61 | 125 | 90 |
| Tax % | 25% | 25% | 28% | 28% | 26% | 26% | 26% | 22% | 25% | 27% | 26% | 25% | 24% | 28% |
| Net Profit | 50 | 27 | 33 | 38 | 49 | 47 | 44 | 46 | 49 | 43 | 42 | 45 | 95 | 65 |
| EPS (₹) | 9.74 | 5.33 | 6.54 | 7.52 | 9.56 | 9.28 | 8.56 | 9 | 9.67 | 8.4 | 8.26 | 8.87 | 18.5 | — |
Sep 2026: from the results filed on 3 Nov 2026, ahead of the full statement, so some rows are blank.
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 476 | 484 | 501 | 616 | 846 | 993 | 1,242 | 1,542 | 1,683 | 1,441 | 1,572 | 1,536 | 1,658 |
| Expenses | 390 | 393 | 405 | 499 | 682 | 736 | 812 | 1,216 | 1,335 | 1,189 | 1,280 | 1,251 | 1,317 |
| Operating Profit | 87 | 91 | 95 | 118 | 164 | 257 | 430 | 326 | 348 | 252 | 291 | 285 | 342 |
| OPM % | 18% | 19% | 19% | 19% | 19% | 26% | 35% | 21% | 21% | 17% | 19% | 19% | 21% |
| Other Income | 2 | 2 | 1 | 2 | 4 | 40 | 6 | 14 | 9 | 14 | 30 | 32 | 33 |
| Interest | 10 | 8 | 8 | 8 | 15 | 10 | 6 | 3 | 3 | 4 | 1 | 1 | 1 |
| Depreciation | 11 | 13 | 14 | 16 | 23 | 27 | 29 | 35 | 45 | 59 | 71 | 72 | 72 |
| PBT | 67 | 72 | 74 | 96 | 130 | 260 | 401 | 302 | 309 | 202 | 249 | 243 | 302 |
| Tax % | 32% | 31% | 32% | 33% | 36% | 17% | 26% | 26% | 26% | 26% | 25% | 26% | — |
| Net Profit | 45 | 50 | 50 | 64 | 84 | 215 | 295 | 225 | 229 | 149 | 186 | 180 | 225 |
| EPS (₹) | 8.91 | 9.77 | 9.87 | 12.61 | 16.42 | 42.21 | 57.91 | 44.04 | 44.75 | 29.12 | 36.39 | 35.19 | 44.03 |
| Div. Payout % | 18% | 41% | 20% | 22% | 20% | 19% | 17% | 23% | 22% | 34% | 28% | 28% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 165 | 189 | 235 | 287 | 355 | 526 | 782 | 980 | 1,159 | 1,257 | 1,392 | 1,523 |
| Borrowings | 135 | 111 | 120 | 181 | 165 | 87 | 47 | 23 | 88 | 3 | 6 | 1 |
| Other Liabilities | 93 | 95 | 147 | 159 | 218 | 160 | 306 | 359 | 335 | 314 | 381 | 362 |
| Total Liabilities | 402 | 406 | 512 | 637 | 749 | 783 | 1,145 | 1,371 | 1,592 | 1,584 | 1,789 | 1,896 |
| Fixed Assets | 151 | 187 | 220 | 355 | 376 | 423 | 458 | 629 | 719 | 1,089 | 1,044 | 1,015 |
| CWIP | 31 | 16 | 35 | 18 | 43 | 45 | 138 | 143 | 352 | 36 | 52 | 130 |
| Investments | 2 | 2 | 1 | 1 | 1 | 0 | 30 | 0 | 0 | 0 | 0 | 51 |
| Other Assets | 218 | 201 | 256 | 262 | 328 | 315 | 520 | 600 | 521 | 459 | 693 | 700 |
| Total Assets | 402 | 406 | 512 | 637 | 749 | 783 | 1,145 | 1,371 | 1,592 | 1,584 | 1,789 | 1,896 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 61 | 101 | 63 | 102 | 144 | 188 | 364 | 205 | 248 | 275 | 263 | 239 |
| Investing | −31 | −35 | −65 | −132 | −67 | −41 | −213 | −206 | −277 | −121 | −196 | −137 |
| Financing | −36 | −68 | −2 | 32 | −60 | −135 | −86 | −57 | 8 | −140 | −49 | −56 |
| Net Cash Flow | −6 | −2 | −3 | 2 | 17 | 12 | 65 | −58 | −21 | 13 | 18 | 45 |
| Free Cash Flow | 20 | 66 | −1 | −33 | 75 | 111 | 208 | −41 | −55 | 153 | 216 | 111 |
| CFO/EBITDA | 95 | 128 | 88 | 103 | 109 | 96 | 108 | 86 | 92 | 123 | 108 | 101 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 76 | 68 | 71 | 73 | 66 | 60 | 67 | 66 | 56 | 56 | 54 | 55 |
| Inventory Days | 105 | 92 | 165 | 99 | 88 | 67 | 91 | 76 | 82 | 85 | 75 | 57 |
| Days Payable | 58 | 63 | 120 | 78 | 104 | 57 | 133 | 105 | 84 | 85 | 80 | 70 |
| Cash Conversion Cycle | 123 | 96 | 116 | 94 | 51 | 71 | 25 | 36 | 53 | 56 | 48 | 42 |
| Working Capital Days | 93 | 87 | 84 | 76 | 56 | 54 | 26 | 35 | 28 | 47 | 42 | 49 |
| ROCE % | 26% | 26% | 24% | 25% | 29% | 41% | 56% | 33% | 28% | 16% | 19% | 17% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Alkyl Amines Chemicals insights
60 extracted metrics across FY12–FY27.
Documents
- Q4 FY26 concall · May 2026Transcript
- Q2 FY26 concall · Nov 2025Transcript Recording
- Q4 FY25 concall · May 2025Transcript
- Q2 FY25 concall · Nov 2024Transcript
- Q4 FY24 concall · May 2024Transcript PPT Recording
- 3 Nov 2026
- 4 Aug 2026
- 5 May 2026
- 3 Feb 2026
- 14 Aug 2025
- 24 Mar 2026
- 26 Dec 2025
- 30 Sep 2024
- 5 Jul 2024
- 29 May 2023
- General announcements 8 Oct 2026
Frequently Asked Questions about Alkyl Amines Chemicals
What does Alkyl Amines Chemicals Ltd do?
Where is Alkyl Amines Chemicals Ltd (ALKYLAMINE) listed?
Which sector does Alkyl Amines Chemicals Ltd belong to?
What is the PE ratio of Alkyl Amines Chemicals Ltd?
What is the 52-week high and low of Alkyl Amines Chemicals Ltd?
Does Alkyl Amines Chemicals Ltd pay dividends?
What is the Return on Equity (ROE) of Alkyl Amines Chemicals Ltd?
Company Information
Incorporated in 1979 by Mr Yogesh Kothari, Alkyl Amines is a leading manufacturer of aliphatic amines in India. Aliphatic amines are products derived from Ammonia (NH3) by displacement of H2 in the Ammonia molecule by other radicals (R) such as Methyl, Ethyl and Propyl.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/ALKYLAMINE.md for Alkyl Amines Chemicals Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.